Our vision for the Department of Obstetrics, Gynecology and Reproductive Biology at the Michigan State University College of Human Medicine is to be the leader in the clinical translation of cutting edge research to the patients and communities that we serve. We are focused on ensuring that our research is translated to the health care needs of women across their life spans and in diverse communities. Our faculty members have achieved national recognition for this research. Since 2009, our department has ranked in the top 23 of 135 departments of obstetrics and gynecology across the country in National Institutes of Health funding for research. We have recruited accomplished researchers in women’s health, including physicians, nurses, sociologists, clinical translational scientists and epidemiologists focused not only on the medical aspects, but on the social disparities that threaten women’s health. Collaborating with each other and with our health care partners, we are:
- Unraveling the causes and pursuing better treatments for infertility.
- Seeking better therapies for endometriosis, a painful condition that afflicts as many as 1 in 10 women of reproductive age.
- Studying the connection between endometriosis and endometrial and ovarian cancers and looking for possible genetic targets for treatment.
- Identifying the mechanisms that cause uterine and ovarian cancer.
- Researching inflammation as a cause of premature births and developing ways to prevent it.
- Examining the health implications of assisted reproductive technology, including whether it is associated with birth defects and later health problems in children and their mothers.
- Leveraging the resources of other health care agencies and community groups to give Medicaid beneficiaries the best prenatal care in the most cost-effective way, thus helping assure that they and their babies will be healthy.
- Working within families to erase health disparities and raise awareness among African-American, Latino and Arab women about the importance of screening and prevention of breast and cervical cancers.
Our research programs rest on three departmental pillars, which include supporting unparalleled health services to women at home and nationally, educating exemplary physicians and scholars, and discovering and disseminating innovative medical knowledge. We look forward to sharing with you the various departmental programs and the impact they have on the everyday lives of women.
Richard E. Leach, M.D., FACOG, FACS
Professor and Chair
Department of Obstetrics, Gynecology and Reproductive Biology
Stacey Missmer, Sc.D. Is appointed Professor in the Department of Obstetrics, Gynecology and Reproductive Biology.
Dr. Missmer joins us from Departments of Obstetrics and Gynecology and Epidemiology at Harvard University. Dr. Missmer is internationally known for her research in women’s health including Endometriosis and Assisted Reproductive Technology Outcomes Research. Dr. Missmer is joining the College in support of the MSU Global Impact Initiative. Please join us in welcoming Dr. Missmer.
The title of his project is SWI/SNF chromatin remodeling and Pl3-kinase pathway crosstalk mechanisms in ovarian cancer. Dr. Chandler aims to identify the mechanism of ARID1A-PIK3CA functional cooperatively in endometriosis-associated ovarian cancers. His research will help to identify signaling pathway co-dependencies and drug targets in ovarian cancers with limited therapeutic options. (view biography)
National Institutes of Health, Fogarty International Center K01 Career Development Award. The title of his project is “Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity.” Cris is currently in Romania for 1 year conducting his studies. (view birography)
Karen Racicot, Ph.D is the recipient of the 2016 Jean P. Schultz Biomedical Research Endowment Award
The title of her project is “Maternal Viral Infections and Fetal Brain Development”. Dr. Racicot’s research focus is to understand the regulation of inflammation and innate immune cells at the maternal-fetal interface and determine how they affect fetal development and maternal health. (view biography)
Yutaka Shoji, Ph.D is the recipient of the Ovarian Cancer Research Fund’s 2015 LIZ TILBERIS EARLY CAREER AWARD.
The title of his project is "ARID1A Regulates ATAD2 in Ovarian Cancer “ Dr.Shoji’s research focus is on the ATAD2 gene in gynecologic cancer.
Frontiers in Epigenetics in Reproduction Symposium
Announcing the first annual Frontiers in Epigenetics in Reproduction Symposium on May 12, 2017 in Grand Rapids, MI. This inaugural symposium will focus on the Epigenetics of Maternal and Paternal Effects and is cosponsored by the Van Andel Research Institute and Michigan State University. view / download brochure
To contribute to For The Love of a Woman Discovery Fund, which supports new discoveries in Gynecological cancer, reproductive health and maternal infant health GO TO OUR FORM. For more information please contact the Advancement Office at 1-855-678-7444.